Infectious Disease Diagnostics – Products

Thermo Fisher Scientific Inc. today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit, and TaqPath COVID-19 CE-IVD RT-PCR Kit, which test for the presence of SARS-CoV-2, are not impacted by the emerging B.1.1.529, or Omicron variant, enabling accurate test results.

Download this whitepaper to discover how to overcome the limitations of PCR testing, how RT-qPCR will impact diagnostics both in lab and at point of care and how RT-qPCR is driving new methods and applications.

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays.

Luas Diagnostics has announced the launch of their enhanced test to determine immunity to COVID-19 post infection or vaccination. The upgraded offering follows the development of a smartphone app and data management software specific to the Luas product, by Bond Digital Health.

A state-of-the-art former Lighthouse Lab at the Charnwood Campus was officially opened by Jane Hunt MP, having been acquired by the global whole genome sequencing company, Dante Labs.

Autoscribe Informatics has announced the release of a LIMS specifically optimized for Covid testing.

Owlstone Medical has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs.

Bio-Rad Laboratories, Inc. has announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.